Meta-analysis: Preoperative transcatheter arterial chemoembolization does not improve prognosis of patients with resectable hepatocellular carcinoma

BMC Gastroenterology

Volumn 13, Issue 1, 2013, Pages

  Zhou, Yanming ^a   Zhang, Xiaofeng ^b   Wu, Lupeng ^a   Ye, Feng ^a   Su, Xu ^a   Shi, Lehua ^b   Li, Bin ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Prognosis; Transcatheter arterial chemoembolization

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CHEMOEMBOLIZATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER SURGERY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MORBIDITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PREOPERATIVE TREATMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY ANALYSIS; SURVIVAL RATE; SURVIVAL TIME; SYSTEMATIC REVIEW; TREATMENT RESPONSE;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; CONTROLLED CLINICAL TRIALS AS TOPIC; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PREOPERATIVE CARE; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84875024199     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-13-51     Document Type: Article

References (48)

1. Forner A, Hessheimer AJ, Isabel Real M. Treatment of hepatocellular carcinoma. Crit Rev Oncol Hematol 2006, 60:89-98. 10.1016/j.critrevonc.2006.06.001, 16860993.
2. Katz SC, Shia J, Liau KH. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma. Ann Surg 2009, 249:617-623. 10.1097/SLA.0b013e31819ed22f, 19300227.
3. Fan ST, Mau Lo C, Poon RT. Continuous improvement of survival outcomes of resection of hepatocellular carcinoma: a 20-year experience. Ann Surg 2011, 253:745-758. 10.1097/SLA.0b013e3182111195, 21475015.
4. Zhou Y, Sui C, Li B. Safety and efficacy of trisectionectomy for hepatocellular carcinoma. ANZ J Surg 2011, 81:895-899. 10.1111/j.1445-2197.2010.05605.x, 22507416.
5. Shrager B, Jibara G, Schwartz M. Resection of hepatocellular carcinoma without cirrhosis. Ann Surg 2012, 255:1135-1143. 10.1097/SLA.0b013e31823e70a3, 22258064.
6. Tung-Ping Poon R, Fan ST, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 2000, 232:10-24. 10.1097/00000658-200007000-00003, 1421103, 10862190.
7. Bruix J, Sherman M. Practice guidelines committee. American association for the study of liver diseases. Management of hepatocellular carcinoma. Hepatology 2005, 42:1208-1236. 10.1002/hep.20933, 16250051.
8. Higuchi T, Kikuchi M, Okazaki M. Hepatocellular carcinoma after transcatheter hepatic arterial embolization. A histopathologic study of 84 resected cases. Cancer 1994, 73:2259-2267. 10.1002/1097-0142(19940501)73:9<2259::AID-CNCR2820730905>3.0.CO;2-P, 7513245.
9. Imaoka S, Sasaki Y, Shibata T. A pre-operative chemoembolization therapy using lipiodol, cisplatin and gelatin sponge for hepatocellular carcinoma. Cancer Chemother Pharmacol 1989, 23:S126-S128. 10.1007/BF00647258, 2538259.
10. Majno PE, Adam R, Bismuth H. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 1997, 226:688-701. 10.1097/00000658-199712000-00006, 1191140, 9409568.
11. Di Carlo V, Ferrari G, Castoldi R. Pre-operative chemoembolization of hepatocellular carcinoma in cirrhotic patients. Hepatogastroenterology 1998, 45:1950-1954.
12. Nagasue N, Galizia G, Kohno H. Adverse effects of preoperative hepatic artery chemoembolization for resectable hepatocellular carcinoma: a retrospective comparison of 138 liver resections. Surgery 1989, 106:81-86.
13. Adachi E, Matsumata T, Nishizaki T. Effects of preoperative transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma. The relationship between postoperative course and tumor necrosis. Cancer 1993, 72:3593-3598. 10.1002/1097-0142(19931215)72:12<3593::AID-CNCR2820721208>3.0.CO;2-T, 8252473.
14. Wu CC, Ho YZ, Ho WL. Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal. Br J Surg 1995, 82:122-126. 10.1002/bjs.1800820141, 7881929.
15. Yamasaki S, Hasegawa H, Kinoshita H. A prospective randomized trial of the preventive effect of pre-operative transcatheter arterial embolization against recurrence of hepatocellular carcinoma. Jpn J Cancer Res 1996, 87:206-211. 10.1111/j.1349-7006.1996.tb03160.x, 8609071.
16. Zhou WP, Lai EC, Li AJ. A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma. Ann Surg 2009, 249:195-202. 10.1097/SLA.0b013e3181961c16, 19212170.
17. Wang X, Li J, Peng Y. Influence of preoperative transarterial chemoembolization on the prognosis for patients with resectable hepatocellular carcinoma: a meta-analysis of randomized trials. Hepatogastroenterology 2011, 58:869-874.
18. Rerkasem K, Rothwell PM. Meta-analysis of small randomized controlled trials in surgery may be unreliable. Br J Surg 2010, 97:466-469. 10.1002/bjs.6988, 20155790.
19. Mathurin P, Raynard B, Dharancy S. Meta-analysis: evaluation of adjuvant therapy after curative liver resection for hepatocellular carcinoma. Aliment Pharmacol Ther 2003, 17:1247-1261. 10.1046/j.1365-2036.2003.01580.x, 12755838.
20. Abraham NS, Byrne CJ, Young JM. Meta-analysis of well-designed nonrandomized comparative studies of surgical procedures is as good as randomized controlled trials. J Clin Epidemiol 2010, 63:238-245. 10.1016/j.jclinepi.2009.04.005, 19716267.
21. Jadad AR, Moore RA, Carroll D. Assessment the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 1996, 17:1-12. 10.1016/0197-2456(95)00134-4, 8721797.
22. Slim K, Nini E, Forestier D. Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg 2003, 73:712-716. 10.1046/j.1445-2197.2003.02748.x, 12956787.
23. Kaibori M, Tanigawa N, Matsui Y. Influence of transcatheter arterial chemoembolization on the prognosis after hepatectomy for hepatocellular carcinoma in patients with severe liver dysfunction. Anticancer Res 2006, 26:3685-3692.
24. Kaibori M, Tanigawa N, Kariya S. A prospective randomized controlled trial of preoperative whole-liver chemolipiodolization for hepatocellular carcinoma. Dig Dis Sci 2012, 57:1404-1412. 10.1007/s10620-012-2029-3, 22271410.
25. Gerunda GE, Neri D, Merenda R. Role of transarterial chemoembolization before liver resection for hepatocarcinoma. Liver Transpl 2000, 6:619-626. 10.1053/jlts.2000.8312, 10980062.
26. Zhang Z, Liu Q, He J. The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma. Cancer 2000, 89:2606-2612. 10.1002/1097-0142(20001215)89:12<2606::AID-CNCR13>3.0.CO;2-T, 11135222.
27. Luo YQ, Wang Y, Chen H. Influence of preoperative transcatheter arterial chemoembolization on liver resection in patients with resectable hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2002, 1:523-526.
28. Harada T, Matsuo K, Inoue T. Is preoperative hepatic arterial chemoembolization safe and effective for hepatocellular carcinoma?. Ann Surg 1996, 224:4-9. 10.1097/00000658-199607000-00002, 1235240, 8678616.
29. Uchida M, Kohno H, Kubota H. Role of preoperative transcatheter arterial oily chemoembolization for resectable hepatocellular carcinoma. World J Surg 1996, 20:326-331. 10.1007/s002689900052, 8661839.
30. Paye F, Jagot P, Vilgrain V. Preoperative chemoembolization of hepatocellular carcinoma: a comparative study. Arch Surg 1998, 133:767-772. 10.1001/archsurg.133.7.767, 9688007.
31. Lu CD, Peng SY, Jiang XC. Preoperative transcatheter arterial chemoembolization and prognosis of patients with hepatocellular carcinomas: retrospective analysis of 120 cases. World J Surg 1999, 23:293-300. 10.1007/PL00013185, 9933702.
32. Ochiai T, Sonoyama T, Hironaka T. Hepatectomy with chemoembolization for treatment of hepatocellular carcinoma. Hepatogastroenterol 2003, 50:750-755.
33. Sugo H, Futagawa S, Beppu T. Role of preoperative transcatheter arterial chemoembolization for resectable hepatocellular carcinoma: relation between postoperative course and the pattern of tumor recurrence. World J Surg 2003, 27:1295-1299. 10.1007/s00268-003-6817-y, 14574482.
34. Sasaki A, Iwashita Y, Shibata K. Preoperative transcatheter arterial chemoembolization reduces long-term survival rate after hepatic resection for resectable hepatocellular carcinoma. Eur J Surg Oncol 2006, 32:773-779. 10.1016/j.ejso.2006.04.002, 16797156.
35. Chen XP, Hu DY, Zhang ZW. Role of mesohepatectomy with or without transcatheter arterial chemoembolization for large centrally located hepatocellular carcinoma. Dig Surg 2007, 24:208-213. 10.1159/000102901, 17522469.
36. Choi GH, Kim DH, Kang CM. Is preoperative transarterial chemoembolization needed for a resectable hepatocellular carcinoma?. World J Surg 2007, 31:2370-2377. 10.1007/s00268-007-9245-6, 17912587.
37. Kim IS, Lim YS, Lee HC. Pre-operative transarterial chemoembolization for resectable hepatocellular carcinoma adversely affects post-operative patient outcome. Aliment Pharmacol Ther 2008, 27:338-345.
38. Lee KT, Lu YW, Wang SN. The effect of preoperative transarterial chemoembolization of resectable hepatocellular carcinoma on clinical and economic outcomes. J Surg Oncol 2009, 99:343-350. 10.1002/jso.21248, 19226530.
39. Kang JY, Choi MS, Kim SJ. Long-term outcome of preoperative transarterial chemoembolization and hepatic resection in patients with hepatocellular carcinoma. Korean J Hepatol 2010, 16:383-388. 10.3350/kjhep.2010.16.4.383, 3304614, 21415582.
40. Yamashita YI, Takeishi K, Tsuijita E. Beneficial effects of preoperative lipiodolization for resectable large hepatocellular carcinoma (≥5 cm in diameter). J Surg Oncol 2012, 106:498-503. 10.1002/jso.23098, 22442003.
41. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 2003, 37:429-442. 10.1053/jhep.2003.50047, 12540794.
42. Bruix J, Llovet JM, Castells A. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution. Hepatology 1998, 27:1578-1583. 10.1002/hep.510270617, 9620330.
43. Ikeda K, Saitoh S, Tsubota A. Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma. Cancer 1993, 71:19-25. 10.1002/1097-0142(19930101)71:1<19::AID-CNCR2820710105>3.0.CO;2-I, 8380116.
44. Huang J, He X, Lin X. Effect of preoperative transcatheter arterial chemoembolization on tumor cell activity in hepatocellular carcinoma. Chin Med J 2000, 113:446-448.
45. Liou TC, Shih SC, Kao CR. Pulmonary metastasis of hepatocellular carcinoma associated with transarterial chemoembolization. J Hepatol 1995, 23:563-568. 10.1016/0168-8278(95)80063-8, 8583145.
46. Bonfil RD, Bustuoabad OD, Ruggiero RA. Tumor necrosis can facilitate the appearance of metastases. Clin Exp Metastasis 1988, 6:121-129. 10.1007/BF01784843, 3345611.
47. Xiao EH, Li JQ, Huang JF. Effects of p53 on apoptosis and proliferation of hepatocellular carcinoma cells treated with transcatheter arterial chemoembolization. World J Gastroenterol 2004, 10:190-194.
48. Xiao EH, Guo D, Bian DJ. Effect of preoperative transcatheter arterial chemoembolization on angiogenesis of hepatocellular carcinoma cells. World J Gastroenterol 2009, 15:4582-4586. 10.3748/wjg.15.4582, 2752005, 19777619.